Cancer Vaccines Concept

subject area of

• A Multicenter Open-Label Study to Assess the Safety of a New Formulation of BLP25 Liposome Vaccine in Patients With Unresectable Stage III Non–Small-Cell Lung Cancer  Journal Articles
• A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein–Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer  Journal Articles
• A hepatic stem cell vaccine is superior to an embryonic stem cell vaccine in the prophylaxis and treatment of murine hepatocarcinoma.  Journal Articles
• A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer  Journal Articles
• A rational relationship: Oncolytic virus vaccines as functional partners for adoptive T cell therapy  Journal Articles
• Adenoviral-transduced dendritic cells are susceptible to suppression by T regulatory cells and promote interleukin 17 production  Journal Articles
• Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination  Journal Articles
• Bone Marrow‐Derived Dendritic Cell Vaccination of Dogs with Naturally Occurring Melanoma by Using Human gp100 Antigen  Journal Articles
• CD4⁺ T‐cell‐mediated anti‐tumor immunity can be uncoupled from autoimmunity via the STAT4/STAT6 signaling axis  Journal Articles
• CD8+ T-cell expansion and maintenance after recombinant adenovirus immunization rely upon cooperation between hematopoietic and nonhematopoietic antigen-presenting cells  Journal Articles
• CTL-Dependent and -Independent Antitumor Immunity Is Determined by the Tumor Not the Vaccine  Journal Articles
• Cancer immunology and canine malignant melanoma: A comparative review  Journal Articles
• Cell-based cancer gene therapy: breaking tolerance or inducing autoimmunity?  Journal Articles
• Cell-free Tumor Microparticle Vaccines Stimulate Dendritic Cells via cGAS/STING Signaling  Journal Articles
• Cellular MRI as a suitable, sensitive non-invasive modality for correlating in vivo migratory efficiencies of different dendritic cell populations with subsequent immunological outcomes  Journal Articles
• Cellular magnetic resonance imaging of monocyte-derived dendritic cell migration from healthy donors and cancer patients as assessed in a scid mouse model  Journal Articles
• Combined Stimulation with Interleukin-18 and Interleukin-12 Potently Induces Interleukin-8 Production by Natural Killer Cells  Journal Articles
• Combining oncolytic virotherapy and tumour vaccination  Journal Articles
• Customized Viral Immunotherapy for HPV-Associated Cancer  Journal Articles
• Dendritic Cells Transduced with an Adenoviral Vector Encoding a Model Tumor-Associated Antigen for Tumor Vaccination  Journal Articles
• Detection of Tumor Antigen-Specific T-Cell Responses After Oncolytic Vaccination  Journal Articles
• Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines  Journal Articles
• Endogenous T cells prevent tumor immune escape following adoptive T cell therapy  Journal Articles
• Engineering Dendritic Cells to Enhance Cancer Immunotherapy  Journal Articles
• Enhanced Antitumor Immunity Elicited by Dendritic Cell Vaccines Is a Result of Their Ability to Engage Both CTL and IFNγ-producing NK Cells  Journal Articles
• Enhanced HER-2/neu-specific antitumor immunity by cotransduction of mouse dendritic cells with two genes encoding HER-2/neu and alpha tumor necrosis factor  Journal Articles
• Enhanced Immune Response to the Melanoma Antigen gp100 Using Recombinant Adenovirus-Transduced Dendritic Cells  Journal Articles
• Enhanced antitumor immunity elicited by dendritic cell vaccines is a result of their ability to engage both CTL and IFN gamma-producing NK cells.  Journal Articles
• Enhanced immunotherapeutic profile of oncolytic virus-based cancer vaccination using cyclophosphamide preconditioning  Journal Articles
• Enhanced protein expression by internal ribosomal entry site-driven mRNA translation as a novel approach for in vitro loading of dendritic cells with antigens  Journal Articles
• Enhancing Immune Responses to Cancer Vaccines Using Multi-Site Injections  Journal Articles
• Genetically modified dendritic cells in cancer therapy: Implications for transfusion medicine  Journal Articles
• Genetically modified dendritic cells prime autoreactive T cells through a pathway independent of CD40L and interleukin 12: implications for cancer vaccines.  Journal Articles
• Going viral with cancer immunotherapy  Journal Articles
• Harnessing Oncolytic Virus-mediated Antitumor Immunity in an Infected Cell Vaccine  Journal Articles
• High-dose chemotherapy augments the efficacy of recombinant adenovirus vaccines and improves the therapeutic outcome  Journal Articles
• IL-15 and Type I Interferon Are Required for Activation of Tumoricidal NK Cells by Virus-Infected Dendritic Cells  Journal Articles
• Immuno-gene therapy approaches for cancer: from in vitro studies to clinical trials  Journal Articles
• Immunotherapy Can Reject Intracranial Tumor Cells without Damaging the Brain despite Sharing the Target Antigen  Journal Articles
• Immunotherapy-induced CD8+ T Cells Instigate Immune Suppression in the Tumor  Journal Articles
• Induction of ErbB-2/neu-specific protective and therapeutic antitumor immunity using genetically modified dendritic cells: enhanced efficacy by cotransduction of gene encoding IL-12  Journal Articles
• Induction of specific human cytotoxic T cells using dendritic cells transduced with an adenovector encoding rat epidermal growth factor receptor 2  Journal Articles
• Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study  Journal Articles
• Maraba Virus as a Potent Oncolytic Vaccine Vector  Journal Articles
• Maraba virus-vectored cancer vaccines represent a safe and novel therapeutic option for cats  Journal Articles
• Mesenchymal Stromal Cells Expressing ErbB-2/neu Elicit Protective Antibreast Tumor Immunity In vivo, Which Is Paradoxically Suppressed by IFN-γ and Tumor Necrosis Factor-α Priming  Journal Articles
• Multi-Stability and Multi-Instability Phenomena in a Mathematical Model of Tumor-Immune-Virus Interactions  Journal Articles
• Neoadjuvant Vaccination Provides Superior Protection against Tumor Relapse following Surgery Compared with Adjuvant Vaccination  Journal Articles
• Oncolytic Maraba virus armed with tumor antigen boosts vaccine priming and reveals diverse therapeutic response patterns when combined with checkpoint blockade in ovarian cancer  Journal Articles
• Oncolytic Viruses: Therapeutics With an Identity Crisis  Journal Articles
• Preclinical development of peptide vaccination combined with oncolytic MG1-E6E7 for HPV-associated cancer  Journal Articles
• Preface  Journal Articles
• Prolonged Culture of Vaccine-Primed Lymphocytes Results in Decreased Antitumor Killing and Change in Cytokine Secretion  Journal Articles
• Randomized Phase IIB Trial of BLP25 Liposome Vaccine in Stage IIIB and IV Non–Small-Cell Lung Cancer  Conferences
• Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer  Journal Articles
• Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial  Journal Articles
• Sarcomas and the Immune System: Implications for Therapeutic Strategies  Journal Articles
• Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination  Journal Articles
• Surgical Stress Abrogates Pre-Existing Protective T Cell Mediated Anti-Tumor Immunity Leading to Postoperative Cancer Recurrence  Journal Articles
• T-cell immunity generated by recombinant adenovirus vaccines  Journal Articles
• Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial  Journal Articles
• Therapeutic options in advanced prostate cancer: Present and future  Journal Articles
• Tn-MUC1 DC Vaccination of Rhesus Macaques and a Phase I/II Trial in Patients with Nonmetastatic Castrate-Resistant Prostate Cancer  Journal Articles
• Tumor Protection Following Vaccination With Low Doses of Lentivirally Transduced DCs Expressing the Self-antigen erbB2  Journal Articles
• Type I IFN signaling on dendritic cells is required for NK cell-mediated anti-tumor immunity  Journal Articles
• Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial  Journal Articles
• Vaccination-Induced Autoimmune Vitiligo Is a Consequence of Secondary Trauma to the Skin  Journal Articles
• Vesicular Stomatitis Virus as a Novel Cancer Vaccine Vector to Prime Antitumor Immunity Amenable to Rapid Boosting With Adenovirus  Journal Articles
• Vesicular stomatitis virus: re-inventing the bullet  Journal Articles
• [Ad hTRP2 - mediated immunity against melanoma is enhanced by dendritic cells pulsed with peptide].  Journal Articles